Covid 19 Medicine
- All
- News
- Videos
-
Chinese Turn To Traditional Remedies To Fight Covid Amid Drug Shortage
President Xi Jinping has promoted traditional Chinese medicine since the start of the pandemic, while health officials have hailed its "important role" in fighting the coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
Delhi Government Sanctions Rs 104 Crore For Hospitals Amid Covid Scare
The Delhi government on Monday approved a budget of Rs 104 crore for hospitals to procure general medicines as part of preparations to deal with emergency situations amid a surge in Covid cases in some countries.
-
Amid Covid Surge, China Says Medicines In "Adequate Supply"
Amid a rise in COVID-19 cases, the Chinese Foreign Ministry said that they have "expanded production capacity" of medical supplies amid reports of a shortage of fever and cold drugs medicines.
-
'Get Your Booster Shot At Earliest': Top Indian Doctors' Body's Warning
It appealed to the government to upscale the preparedness "for any such situation as seen in 2021" by issuing necessary instructions to the concerned Ministries and Departments to make available the emergency medicines, oxygen supply, and ambulances.
-
China Covid Surge Leads To Shortage Of Crucial Drug In Taiwan
Taiwan authorities may taking action against people if they continue to buy Panadol in huge quantities.
-
In North Korea's Covid Outbreak, Over A Million Cases Of "Fever", 50 Dead
Kim Jong Un slammed North Korea's pandemic response and ordered the army to help distribute medicine, state media said Monday, as the country said 50 people had died since first reporting an outbreak of COVID-19.
-
2021 Covid Mistakes Being Repeated, Avoid Unnecessary Medicines, Tests: Doctors To Government
As many as 32 prominent doctors from India and abroad have written a letter to the Union as well as state governments and warned about "inappropriate" diagnostic methods and medications being used to deal with the current wave of the pandemic.
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Natco Pharma Gains On Getting Emergency Use Approval Of COVID-19 Drug
Natco Pharma shares gained as much as 4.27% to hit an intraday high of Rs 935 after it received emergency use approval for drug to treat COVID-19 patients.
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
-
For Many Indians, Twitter Has Become a Hope to Survive in This Pandemic
The deadliest attack of coronavirus has influenced people on Twitter and other social media platforms to help others by sharing details about medicines, hospitals, ICUs, and plasma donors.
-
Pharma Shares Gain On Higher Demand For Medicines As Covid-19 Cases Rise
Rising Covid-19 cases in the country is leading to higher demand for medicines which is driving up the share prices of drugmakers, analysts said.
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
Chinese Turn To Traditional Remedies To Fight Covid Amid Drug Shortage
President Xi Jinping has promoted traditional Chinese medicine since the start of the pandemic, while health officials have hailed its "important role" in fighting the coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
Delhi Government Sanctions Rs 104 Crore For Hospitals Amid Covid Scare
The Delhi government on Monday approved a budget of Rs 104 crore for hospitals to procure general medicines as part of preparations to deal with emergency situations amid a surge in Covid cases in some countries.
-
Amid Covid Surge, China Says Medicines In "Adequate Supply"
Amid a rise in COVID-19 cases, the Chinese Foreign Ministry said that they have "expanded production capacity" of medical supplies amid reports of a shortage of fever and cold drugs medicines.
-
'Get Your Booster Shot At Earliest': Top Indian Doctors' Body's Warning
It appealed to the government to upscale the preparedness "for any such situation as seen in 2021" by issuing necessary instructions to the concerned Ministries and Departments to make available the emergency medicines, oxygen supply, and ambulances.
-
China Covid Surge Leads To Shortage Of Crucial Drug In Taiwan
Taiwan authorities may taking action against people if they continue to buy Panadol in huge quantities.
-
In North Korea's Covid Outbreak, Over A Million Cases Of "Fever", 50 Dead
Kim Jong Un slammed North Korea's pandemic response and ordered the army to help distribute medicine, state media said Monday, as the country said 50 people had died since first reporting an outbreak of COVID-19.
-
2021 Covid Mistakes Being Repeated, Avoid Unnecessary Medicines, Tests: Doctors To Government
As many as 32 prominent doctors from India and abroad have written a letter to the Union as well as state governments and warned about "inappropriate" diagnostic methods and medications being used to deal with the current wave of the pandemic.
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Natco Pharma Gains On Getting Emergency Use Approval Of COVID-19 Drug
Natco Pharma shares gained as much as 4.27% to hit an intraday high of Rs 935 after it received emergency use approval for drug to treat COVID-19 patients.
-
19 States Mapped With Remdesivir Manufacturers For Faster Supply
The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement.
-
For Many Indians, Twitter Has Become a Hope to Survive in This Pandemic
The deadliest attack of coronavirus has influenced people on Twitter and other social media platforms to help others by sharing details about medicines, hospitals, ICUs, and plasma donors.
-
Pharma Shares Gain On Higher Demand For Medicines As Covid-19 Cases Rise
Rising Covid-19 cases in the country is leading to higher demand for medicines which is driving up the share prices of drugmakers, analysts said.
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
